Category: by reason for retraction

Persistence pays off for plagiarized author: emails spur retraction, sanctions against researcher

Note: This post has been updated.

Here’s an object lesson for scientists who find out they’ve been ripped off by other researchers: Taking matters into your own hands can produce results.  

An aggrieved author’s doggedness led to the retraction of a 2013 paper that plagiarized his work, along with the revocation of a doctoral degree by one of the scientists responsible for the theft and sanctions against another.

We don’t often get the blow-by-blow, but in this case we have the details to share. The story begins in early 2017, when Andrew Boyle, a professor of cardiac medicine at the University of Newcastle, in Australia, noticed something fishy in an article, “Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway.” The paper had appeared in a journal called Molecular Medicine Reports, from Spandidos.

The article, published by a group from Shandong Provincial Hospital, contained a pair of figures that Boyle recognized from his 2005 article in the Journal of Molecular and Cellular Cardiology. One of the images had been altered, but the other was a patent duplication.

Boyle explained that: Continue reading Persistence pays off for plagiarized author: emails spur retraction, sanctions against researcher

When it comes to authorship, how prolific is too prolific?

John Ioannidis

One of the suggestions we get regularly here at Retraction Watch is something along the lines of “This researcher publishes too much. You should look into that.” But how much is too much?

The phenomenon was the subject of a 2015 paper. It’s also the subject of a new article in Nature by John Ioannidis, of Stanford, and researchers at SciTech Strategies. The new article is unlikely to answer the question of how much is too much. But it provides some fascinating figures on just how often some authors publish, and even more so how they respond when asked just how they manage to publish so much, in the process raising questions about whether measuring productivity and quality in science should involve a ruler for stacked papers. Continue reading When it comes to authorship, how prolific is too prolific?

Japanese university revokes PhD following a retraction

Tokyo Women’s Medical University has stripped a researcher of her PhD, following the retraction of a paper — for data duplication — that was based on her thesis.

The August 30th announcement notes that a degree was revoked on July 20. The announcement does not name the researcher, but refers to degree number 2881, which corresponds to Rika Nakayama’s PhD. The university describes carelessness and errors, but not misconduct.

Here’s a rough Google translation of the announcement: Continue reading Japanese university revokes PhD following a retraction

Cancer journals retract 10 papers, flag 8 more, and apologize for the delay

Bharat Aggarwal

Five journals published by a prominent cancer research society have retracted a total of 10 papers — most of them by a former researcher at the MD Anderson Cancer Center in Houston.

Nine of the 10 retractions share that researcher, Bharat Aggarwal, as an author. Aggarwal — who more than five years ago threatened to sue us for reporting on an investigation into his work — is now up to 28 retractions, and has left his post at MD Anderson. The AACR is also appending an editor’s note to eight of his other papers — but it has not explained the reason for what it acknowledges is a lag in moving on these articles.

“Unfortunately, we have been delayed in correcting the published record, and for this we apologize,” writes the publisher of The American Association for Cancer Research (AACR), Christine Rullo, in a note in this month’s issue of Cancer Research. Rullo doesn’t say how long the journals took to handle the retractions. Continue reading Cancer journals retract 10 papers, flag 8 more, and apologize for the delay

One retraction notice says plagiarism. The other says it was an error in an algorithm. Which was it?

For the second time in a week, we’ve come across a retraction notice that gave the wrong reason for the retraction.

Last week, it was an Elsevier journal that called a plagiarized paper a duplicate of work by the same authors who’d written the original. Today, here’s the story of a chapter in a book published by Springer Nature that manages to list two different reasons for retraction.

According to one notice for “In-silico Analysis of LncRNA-mRNA Target Prediction” in: D. Reddy Edla et al. (eds.), Advances in Machine Learning and Data Science, Advances in Intelligent Systems and Computing 705, the chapter was retracted for plagiarism.

But according to the other notice, the retraction happened because Continue reading One retraction notice says plagiarism. The other says it was an error in an algorithm. Which was it?

UConn prof “recklessly” used false data in NIH grant applications, says Federal watchdog

Li Wang (via UConn)

A liver physiologist at the University of Connecticut with millions of dollars in Federal U.S. funding included false data in half a dozen grant applications, according to the U.S. Office of Research Integrity.

Li Wang, according to the ORI, Continue reading UConn prof “recklessly” used false data in NIH grant applications, says Federal watchdog

Researcher found to have committed misconduct using federal grants is publishing again — and cites those very grants

Michael Miller

A researcher who was found guilty of committing misconduct while using three federal grants has published new findings that cite those grants.

In 2012, the U.S. Office of Research Integrity determined that Michael Miller, a former department chair at the State University of New York (SUNY) Upstate Medical University in Syracuse, had committed misconduct by falsifying and/or fabricating data. The affected research was funded by three grants issued by the National Institute of Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH).

As a result, Miller agreed to not seek federal funding for one year, and then have his research supervised for two years following the debarment. (He ended up getting a gig as a grant services consultant, but lost it in 2013 after he failed to disclose his ORI sanctions to his new employer.)

Recently, Miller published two new papers — both of which cite the three grants, collectively worth millions.

Continue reading Researcher found to have committed misconduct using federal grants is publishing again — and cites those very grants

UPDATED: Elsevier retracts a paper on solar cells that appears to plagiarize a Nature journal. But the reason is…odd.

The similarities between recent papers in two different journals about energy were striking — so striking that a number of people have taken to Twitter and Facebook to let the world know about them.

[1415 UTC, August 29, 2018: See update at the end of this post.]

One paper, “Systematic investigation of the impact of operation conditions on the degradation behaviour of perovskite solar cells,” was authored by a group of researchers in Lausanne, Switzerland and appeared on January 1, 2018 in Nature Energy. Its abstract reads: Continue reading UPDATED: Elsevier retracts a paper on solar cells that appears to plagiarize a Nature journal. But the reason is…odd.

Star researcher in health policy plagiarized a colleague, probe says

Gilbert Welch

Gilbert Welch, one of the most prominent health care policy researchers in the U.S., has been found guilty of research misconduct following an investigation by Dartmouth College, his employer.

According to documents obtained by Retraction Watch, the material was included as part of a high-profile 2016 paper in the New England Journal of Medicine that reported mammograms were more likely to prompt unnecessary treatment for harmless tumors than save lives. Continue reading Star researcher in health policy plagiarized a colleague, probe says

Are you liable for misconduct by scientific collaborators? What a recent court decision could mean for scientists

Richard Goldstein

Retraction Watch readers may have followed our coverage of the case of Christian Kreipke, a former Wayne State researcher who was recently barred from U.S. Federal funding for five years. That punishment followed years of allegations and court cases, along with half a dozen retractions. The case has been complicated, to say the least, and led to a 126-page decision by a judge last month. Here, Boston-based attorney Richard Goldstein, who represented the scientist in Bois v. HHS, the first case to overturn a funding ban by the U.S. Office of Research Integrity (ORI), tries to explain what it could all mean.

Can you commit research misconduct if you fail to detect false data from another scientist? Continue reading Are you liable for misconduct by scientific collaborators? What a recent court decision could mean for scientists